Roshani Mishra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Roshani Mishra has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anurag Snehi Ramavat
Department of Otolaryngology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
1 shared publication - Banumathy Nagamani
ENT Department, PGIMER, Chandigarh, India
1 shared publication - Himanshu Verma
Department of Therapeutics, National Institute for the Empowerment of Persons with Intellectual Disabilities, Secunderabad, India
1 shared publication - Jaimanti Bakshi
Department of Otorhinolaryngology and Head-Neck Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication - Padmavati Khandnor
Department of Computer Science and Engineering, Punjab Engineering College, Chandigarh 160012, India
1 shared publication - Sourabha Kumar Patro
Department of Otolaryngology and Head and Neck Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (5) , 581
Early Detection of Glottic Cancer Through Machine Learning and Acoustic Voice Analysis: A Systematic Review
Purpose: Early detection of glottic cancer is essential for better outcomes, but current diagnostic methods remain largely invasive, highlighting the need for reliable non-invasive alternatives. Acoustic voice signals offer a non-invasive screening input, but their clinical value depends on whether signal-processing features and learned models can distinguish malignancy from acoustically similar benign lesions rather than merely separate pathological from healthy voices. Despite growing research on acoustic analysis combined with machine learning (ML) techniques, no systematic synthesis of this evidence currently exists. Therefore, the present review aimed to identify acoustic features that differentiate early glottic malignancies from both benign vocal fold lesions and normal vocal function using various ML techniques. Method: Following PRISMA 2020 guidelines, a comprehensive literature search was conducted across Scopus, EBSCO, Ovid (Embase), and PubMed databases through November 2025. Eighteen studies met inclusion criteria, and PROBAST was used for quality appraisal of included studies. Data extraction focused on acoustic feature categories, ML techniques, classification performance metrics, and validation strategies. Results: Nine acoustic feature categories emerged, with cepstral coefficients (particularly MFCCs) most prevalent across 55.6% of studies. Binary pathological-versus-normal classification achieved consistently high accuracy (96–98.3%) across both traditional machine learning and deep learning approaches. However, malignant-versus-benign discrimination demonstrated substantially lower performance (81–87.88% accuracy, AUC 0.631–0.91), with voice-only models proving insufficient. Multimodal models incorporating clinical variables or laryngoscopic images achieved higher performance, but their results cannot be attributed to voice features alone. All 17 prediction studies were judged at high overall risk of bias, predominantly because of small effective sample sizes, model-selection optimism, possible data leakage, and limited independent validation. Conclusions: ML can detect broad voice pathology, but current evidence is insufficient to support stand-alone acoustic screening for early glottic cancer. Future studies require clearly defined cancer-specific targets, patient-level analysis, standardized acquisition, nested model development, calibration, and independent multicentervalidation.
- 17 September 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (5) , 581
Open AccessEarly Detection of Glottic Cancer Through Machine Learning and Acoustic Voice Analysis: A Systematic Review
Purpose: Early detection of glottic cancer is essential for better outcomes, but current diagnostic methods remain largely invasive, highlighting the need for reliable non-invasive alternatives. Acoustic voice signals offer a non-invasive screening input, but their clinical value depends on whether signal-processing features and learned models can distinguish malignancy from acoustically similar benign lesions rather than merely separate pathological from healthy voices. Despite growing research on acoustic analysis combined with machine learning (ML) techniques, no systematic synthesis of this evidence currently exists. Therefore, the present review aimed to identify acoustic features that differentiate early glottic malignancies from both benign vocal fold lesions and normal vocal function using various ML techniques. Method: Following PRISMA 2020 guidelines, a comprehensive literature search was conducted across Scopus, EBSCO, Ovid (Embase), and PubMed databases through November 2025. Eighteen studies met inclusion criteria, and PROBAST was used for quality appraisal of included studies. Data extraction focused on acoustic feature categories, ML techniques, classification performance metrics, and validation strategies. Results: Nine acoustic feature categories emerged, with cepstral coefficients (particularly MFCCs) most prevalent across 55.6% of studies. Binary pathological-versus-normal classification achieved consistently high accuracy (96–98.3%) across both traditional machine learning and deep learning approaches. However, malignant-versus-benign discrimination demonstrated substantially lower performance (81–87.88% accuracy, AUC 0.631–0.91), with voice-only models proving insufficient. Multimodal models incorporating clinical variables or laryngoscopic images achieved higher performance, but their results cannot be attributed to voice features alone. All 17 prediction studies were judged at high overall risk of bias, predominantly because of small effective sample sizes, model-selection optimism, possible data leakage, and limited independent validation. Conclusions: ML can detect broad voice pathology, but current evidence is insufficient to support stand-alone acoustic screening for early glottic cancer. Future studies require clearly defined cancer-specific targets, patient-level analysis, standardized acquisition, nested model development, calibration, and independent multicentervalidation.